Parkinsono ligos ir judėjimo sutrikimų asociacija - financials and debts
Company age: 2 y. 6 mo.
Company finances
|
EUR
|
2024
From: 2024-04-12
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 11,860 | 11,151 |
| Profit before tax | 6 | 1,197 |
| Net profit | 6 | 1,197 |
| Equity | 6 | 1,197 |
| Liabilities | 0 | 0 |
| Non-current assets | 0 | 1,197 |
| Current assets | 6 | 0 |
| Total assets | 6 | 1,197 |
|
Financial indicators
|
||
| Revenue change y/y | - | -6.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 100.0% | 100.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 100.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.1% | 10.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.1% | 10.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Social security debts
The company had no debts to Sodra
VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Parkinsono ligos ir judejimo sutrikimu asociacija (code 306721519) is an Association operating in other education n.e.c. In the latest financial year, 2025, the company generated revenue of €11.2K, down 6.0% from €11.9K in 2024. Despite the lower turnover, net profit improved sharply to €1.2K in 2025 from only €6 in 2024, lifting the profit margin to 10.7%. The 2024 result was essentially break-even, while 2025 shows a clearer profit contribution from the same small-scale activity base. The balance sheet remained very small, with total assets and equity both at €1.2K in 2025. Because the equity and asset base is minimal, return measures and asset efficiency appear very high and should be interpreted in that context rather than as indicators of scale. Overall, the company shows stable but limited revenue generation, with a marked improvement in profitability in 2025.